JAMES DEWITT BEARDEN III, MD

Plain English
This study examined how poor nutrition affects the quality of life and mental health of older adults with advanced cancer who are receiving palliative treatment. Researchers found that among 479 patients, 56% had nutritional impairment, which was linked to lower quality of life scores and higher rates of mild depression. Specifically, those with nutritional issues were over four times more likely to be in the lowest quality of life group than those with the highest quality of life. Who this helps: This helps older cancer patients and their caregivers.

Plain English
This study looked at older adults with advanced cancer who were starting chemotherapy to see what factors might predict hospitalizations that were not planned. Researchers found that about 29% of the 369 patients were unexpectedly admitted to the hospital within three months. Having more risk factors, like needing help with daily activities or low albumin levels, significantly increased the chance of hospitalization; for example, 47% of those with 6-7 risk factors were hospitalized. Who this helps: This information benefits patients, doctors, and caregivers by identifying which patients are at greater risk and helping guide their care.

Plain English
This study looked at how giving oncologists a summary of a geriatric assessment (GA) can improve conversations about the physical and functional well-being of older cancer patients. The results showed that 86% of patients in the intervention group talked about these concerns with their doctors, compared to only 59% in the usual care group. This matters because addressing these issues can lead to better care and outcomes for older patients undergoing cancer treatment. Who this helps: This helps older cancer patients receiving treatment.

Plain English
This study looked at how often doctors talked to older cancer patients about the risk of falls and found that conversations were more frequent when doctors used a special assessment tool designed for older patients. Out of 541 patients, 61% who received this assessment tool discussed fall risks, compared to just 10% in the standard care group. This finding highlights the importance of assessing fall risks among older cancer patients to help prevent serious injuries. Who this helps: This helps older cancer patients and their doctors.

Plain English
This study looked at how feelings of uncertainty affect the mental health and quality of life of older adults with advanced cancer. The researchers found that higher levels of uncertainty were linked to increased anxiety, depression, and distress, as well as lower overall quality of life and emotional well-being. For instance, a small increase in uncertainty was associated with a rise in anxiety levels by 0.11 points and a decrease in quality of life by 1.08 points. Who this helps: This research benefits older cancer patients by highlighting the need for better support in managing their uncertainty related to their illness and treatment.

Plain English
In this study, researchers looked at the effectiveness and safety of using a drug called pembrolizumab followed by chemotherapy in patients with newly diagnosed classical Hodgkin lymphoma (cHL), both in early unfavorable and advanced stages. They found that 37% of patients achieved a complete metabolic response after the pembrolizumab treatment, and all patients showed a positive response after the subsequent chemotherapy. This is significant because it demonstrates that this treatment approach works well without needing additional radiation therapy, and it was generally safe for patients. Who this helps: This benefits patients with newly diagnosed classical Hodgkin lymphoma, especially those with larger tumors.

Plain English
This study looked at how well caregivers of cancer patients understand the patients' prognosis compared to their doctors, as well as how this affects the caregivers' mental health and quality of life. Out of 411 caregiver-doctor pairs, only 28% agreed on the prognosis, and those who did not agree had more depressive symptoms, especially if they felt less in control of their situation. This is important because it shows that when caregivers misunderstand the patient's prognosis, it can harm their mental well-being, highlighting the need for better communication between doctors and caregivers. Who this helps: This information is beneficial for patients, caregivers, and doctors.

Plain English
This study looked at how effective the treatment of abiraterone acetate plus prednisone is for Black and White men with advanced prostate cancer that resists hormone therapy. Researchers found that both groups had similar times before the cancer progressed, with Black men showing a slight edge in PSA decline and time to progression, but they also experienced higher rates of serious side effects like hypertension. Understanding these differences is crucial for tailoring treatments and improving outcomes for diverse patient populations. Who this helps: This helps patients and doctors by providing insights into how race can influence treatment effectiveness and side effects in prostate cancer care.

Plain English
This study looked at how well older patients with advanced cancer, their caregivers, and their doctors agree on whether the cancer can be cured. It found that 60% of patients and doctors, and 52% of caregivers and doctors, had differing views on the chances of the cancer disappearing, with severe disagreements in 15% and 16% of these pairs, respectively. This matters because misunderstandings about cancer curability can affect treatment decisions and patient consent. Who this helps: This benefits older cancer patients, their caregivers, and oncologists.

Plain English
This study looked at whether adding a medication called bevacizumab to the standard treatment erlotinib improves outcomes for patients with a specific type of advanced lung cancer known as EGFR-mutant non-small cell lung cancer. The results showed that combining the two drugs did not significantly extend the time patients lived without their disease worsening—17.9 months for the combination versus 13.5 months for erlotinib alone. This matters because it informs doctors about the effectiveness of treatment options, helping them choose the best care for their patients. Who this helps: Patients with advanced EGFR-mutant non-small cell lung cancer.

Plain English
This study looked at how involving older cancer patients and their caregivers as active partners in research impacts clinical trials. They found that it was effective and beneficial for both the researchers and the participants, with this being the largest trial of its kind. Involving patients in research not only improves the studies but also gives valuable insights that can enhance care. Who this helps: This helps patients and their caregivers by making research more relevant to their needs.

Plain English
This study looked at a simple program designed to help breast cancer survivors adjust after their treatment. Researchers involved 92 survivors who either watched a 4-week video and received an educational booklet or received standard care. While participants felt more supported and had clearer expectations about recovery after the program, there were no measurable improvements in their quality of life or worries about cancer. Who this helps: This helps breast cancer survivors looking for support during their recovery.

Plain English
This study focused on a specific protein called BlmI, which is involved in the production of certain natural products, particularly those made by bacteria. Researchers determined its structure and found that it shares similarities with other proteins, but has a unique interaction area that helps it connect with other molecules. They discovered that BlmI can serve as a model for studying both types of carrier proteins involved in this process, which is important for developing new drugs. Who this helps: This helps researchers and drug developers looking to create new treatments using natural compounds.

Plain English
This study looked at two specific enzymes from bacteria found in the human gut, called lactic acid bacteria. Researchers created detailed images of these enzymes to see how they work in breaking down a type of sugar molecule. They found that these enzymes, from the bacteria Lactobacillus plantarum and Streptococcus mutans, effectively break down sugar into glucose, which is important for the bacteria's energy use. Who this helps: This research benefits scientists and doctors studying gut health and its impact on human nutrition.

Plain English
This study looked at how a type of bacteria, Anaeromyxobacter dehalogenans, senses changes in its environment by analyzing specific proteins that help it adapt. Researchers found that this bacterium has many sensor proteins, with two of them showing distinct structures that could help it interact with its surroundings. The findings matter because they provide insights into how this bacterium can be used in cleaning up contaminated environments through its ability to break down harmful substances. Who this helps: This research helps scientists and environmental engineers working on bioremediation.

Plain English
This study looked at how well a drug called bortezomib works alone or with hormone therapy in men with recurrent prostate cancer who had just started to see an increase in PSA levels after previous treatment. Researchers found that bortezomib helped slow the increase of PSA in patients, with 5 out of 8 men on the drug alone showing stable disease, and more than 70% of those receiving the combination therapy achieved complete responses within an average of 42 days. This is important because it offers a new treatment option that can effectively manage the cancer's progression with manageable side effects. Who this helps: This helps men with recurrent prostate cancer and their doctors.

Plain English
This study looked at a new way to analyze red blood cells using an upgraded hematology analyzer that measures them in three dimensions. Researchers tested this method on 154 normal samples and 484 samples from patients with various blood disorders, and found that it could effectively identify and quantify different types of red blood cells, including abnormally shaped ones. This advancement is important because it can reduce the need for manual reviews of blood samples, improving efficiency in diagnosing and treating blood-related conditions. Who this helps: Patients with blood disorders and the healthcare professionals diagnosing them.

Plain English
This study looked at the grades given to all students in all courses at SUNY Geneseo in two different years, 1990 and 2000. It found that grades increased significantly from 1990 to 2000, showing a consistent trend in grading practices across different departments. This matters because it highlights a potential issue of grade inflation in higher education, which can affect how well students are prepared for their future careers. Who this helps: This helps educators and school administrators.

Plain English
This study looked at two different chemotherapy treatments for extensive-stage small-cell lung cancer, comparing a more intensive regimen called CODE with a standard one known as CAV/EP. Researchers found that while CODE led to a better response rate (87% compared to 70% with CAV/EP), it also caused more deaths during treatment (8.2% for CODE vs. 0.9% for CAV/EP), and there was no significant difference in how long patients lived without the cancer worsening or in overall survival time (about 0.98 years for CODE and 0.91 years for CAV/EP). Because CODE has higher toxicity without improved survival benefits, it is not recommended as a treatment option for this type of cancer. Who this helps: This helps patients with extensive-stage small-cell lung cancer by providing clearer treatment options.

Plain English
This study tested the effectiveness of a combination treatment using 5-fluorouracil (5-FU) and a drug called alpha-2a-interferon in 44 patients with advanced stomach cancer who had not yet received chemotherapy. Out of the 40 patients evaluated, 10% had a significant reduction in their cancer, while 25% showed some level of response, with an average survival time of 29 weeks. However, the side effects were serious, with some patients experiencing severe drops in white blood cells and other significant health issues, indicating this treatment isn't better than what's currently available. Who this helps: This mainly benefits patients with advanced stomach cancer and their doctors in understanding treatment options.

Plain English
This study looked at the effects of a substance called methanol-extracted residue of bacillus Calmette-Guerin (MER) when added to standard chemotherapy in 103 patients with advanced non-small-cell lung cancer. The results showed that adding MER did not improve treatment outcomes; both groups had similar response rates of 18%, with a median survival of 21.5 weeks for those without MER and 18.6 weeks for those who received it. This matters because it suggests that adding MER to chemotherapy may not provide any benefit and could lead to more side effects. Who this helps: Patients with extensive non-small-cell lung cancer.

Plain English
This study examined a specific type of protein found in liver cancer cells, which are important for the nucleolus, a part of the cell involved in making ribosomes. Researchers discovered that these proteins, which are modified by adding a phosphate group, can bind to DNA from the same type of cancer cells. This finding is significant because understanding these proteins’ behavior might help improve targeted therapies for liver cancer. Who this helps: This benefits patients with liver cancer and their doctors.

Plain English
This study looked at the stability and bonding strength of the natural proteins in sperm from squids, bulls, and humans when exposed to heat. The researchers discovered that the sperm’s protein structures began to break down at certain temperatures, with human and bull sperm showing a clear step where strong bonds, called disulfide bonds, broke first. These findings help us understand how sperm proteins behave under different conditions, which is important for both fertility treatments and sperm preservation techniques. Who this helps: This helps doctors and researchers working on fertility and reproductive health.

Plain English
This study looked at how bull sperm behaves when heated, specifically focusing on its structure and light properties, known as birefringence. Researchers found that, unlike squid sperm which lost both shape and light properties when heated, bull sperm maintained its shape but changed its birefringence from negative to positive. The study provided specific measurements of bull sperm's light properties, showing that its structure aligns more closely with flat shapes than long, rod-like ones. Who this helps: This research benefits scientists studying sperm behavior and fertility treatments.

Plain English
This study looked at how certain cylindrical molecules, like those found in tobacco mosaic virus and DNA, absorb light that is polarized in different directions. The researchers confirmed their theory by showing that the orientation of these molecules affects how much light they absorb, which can be measured with specific experimental results. This is important because it helps scientists understand the properties of these molecules, which can lead to advances in fields like medicine and material science. Who this helps: This helps researchers and scientists working on viruses, genetics, and materials.